Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 20 papers were listed this time. Here's a few in our areas of research interest:
Behl AS, Goddard KA, Flottemesch TJ, et al. Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer. J Natl Cancer Inst. 2012 Nov 28. [Epub ahead of print] PubMed PMID: 23197490.
Pollock RF, Curtis BH, Smith-Palmer J, et al. A UK Analysis of the Cost-Effectiveness of Humalog Mix75/25 and Mix50/50 Versus Long-Acting Basal Insulin. Adv Ther. 2012 Nov 22. [Epub ahead of print] PubMed PMID: 23179373.
Hiligsmann M, Sedrine WB, Reginster JY. Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women. J Bone Miner Res. 2012 Nov 19. [Epub ahead of print] PubMed PMID: 23165656.
